Business
Press Release Dec 18 2025
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 18, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Travoprost Ophthalmic Solution".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 18, 2025, titled \"Alembic Pharmaceuticals Limited receives USFDA Final Approval for Travoprost Ophthalmic Solution\". View Attachment","length":379,"tagName":"div"}]